COST-EFFECTIVENESS OF WARFARIN CARE BUNDLES AND NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION IN THAILAND

被引：0
|
作者：
Ng, S. S. [1 ]
Nathisuwan, S. [2 ]
Phrommintikul, A. [3 ]
Chaiyakunapruk, N. [4 ]
机构：
[1] Monash Univ Malaysia, Melaka, Malaysia
[2] Mahidol Univ, Bangkok, Thailand
[3] Chiang Mai Univ, Muang, Thailand
[4] Univ Utah, Salt Lake City, UT USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV55
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Mullin, Rachel
    Blazawski, Jon
    Coleman, Craig I.
    PLOS ONE, 2012, 7 (10):
  • [22] Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Anglade, Moise W.
    Dan Pham
    Pisacane, Robyn
    Kluger, Jeffrey
    Coleman, Craig I.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 845 - 851
  • [23] Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation
    Coyle, Doug
    Coyle, Kathryn
    Cameron, Chris
    Lee, Karen
    Kelly, Shannon
    Steiner, Sabine
    Wells, George A.
    VALUE IN HEALTH, 2013, 16 (04) : 498 - 506
  • [24] Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Lip, Gregory Y. H.
    Kongnakorn, Thitima
    Phatak, Hemant
    Kuznik, Andreas
    Lanitiss, Tereza
    Liu, Larry Z.
    Iloeje, Uchenna
    Hernandez, Luis
    Dorian, Paul
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 192 - 210
  • [25] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Wang, Ye
    Xie, Feng
    Kong, Ming Chai
    Lee, Lai Heng
    Ng, Heng Joo
    Ko, Yu
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (06) : 575 - 585
  • [26] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Ye Wang
    Feng Xie
    Ming Chai Kong
    Lai Heng Lee
    Heng Joo Ng
    Yu Ko
    Cardiovascular Drugs and Therapy, 2014, 28 : 575 - 585
  • [27] Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK
    Lip, G. Y. H.
    Lanitis, T.
    Kongnakorn, T.
    Phatak, H.
    Liu, L.
    Lawrence, J.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 864 - 864
  • [28] Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
    Kamel, Hooman
    Easton, J. Donald
    Johnston, S. Claiborne
    Kim, Anthony S.
    NEUROLOGY, 2012, 79 (14) : 1428 - 1434
  • [29] Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
    Harrington, Amanda R.
    Armstrong, Edward P.
    Nolan, Paul E., Jr.
    Malone, Daniel C.
    STROKE, 2013, 44 (06) : 1676 - +
  • [30] Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
    Canestaro, William J.
    Patrick, Amanda R.
    Avorn, Jerry
    Ito, Kouta
    Matlin, Olga S.
    Brennan, Troyen A.
    Shrank, William H.
    Choudhry, Niteesh K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (06): : 724 - +
12345